Literature DB >> 6647496

Vasopressin and oxytocin content in cerebrospinal fluid and in various brain areas after administration of histamine and pentylenetetrazol.

W B Mens, F Laczi, J A Tonnaer, E R de Kloet, T B van Wimersma Greidanus.   

Abstract

The content of vasopressin (AVP) and oxytocin (OXT) in the septum, hippocampus, hypothalamus and cortex was determined at 5 min and 24 hr after peripheral (intraperitoneal) administration of histamine (20.0 mg/kg) and pentylenetetrazol (45.0 mg/kg) and in the cerebrospinal fluid at 24 hr after pentylenetetrazol treatment. At 5 min after administration of histamine the AVP content in the septum was increased whereas the OXT level in the various areas was not changed. At 24 hr, neurohypophyseal peptide contents were unaffected in the brain regions analyzed. Pentylenetetrazol did not alter AVP content at 5 min after its administration, however, the OXT level in the septum and the cortex was diminished. At 24 hr after administration of pentylenetetrazol a decreased AVP content in the hippocampus and in the cortex was observed. In contrast, OXT content in the cortex was increased at this time. AVP and OXT levels in CSF were not changed at 24 hr following pentylenetetrazol treatment. The present results suggest that the levels of neurohypophyseal hormones can be differentially altered in particular brain regions at short- (5 min) and long- (24 hr) term intervals after treatment with histamine or pentylenetetrazol. Long-term changes in AVP and OXT levels after pentylenetetrazol may be implicated in the amnesic properties of this convulsive drug. Furthermore, the present findings point to a possible relationship with previously reported pentylenetetrazol-induced changes in peptide levels in the CSF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6647496     DOI: 10.1016/0091-3057(83)90332-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

Review 1.  Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression.

Authors:  M R Lee; R D Jayant
Journal:  Cell Tissue Res       Date:  2018-12-10       Impact factor: 5.249

2.  Oxytocin Acts in Nucleus Accumbens to Attenuate Methamphetamine Seeking and Demand.

Authors:  Brittney M Cox; Brandon S Bentzley; Helaina Regen-Tuero; Ronald E See; Carmela M Reichel; Gary Aston-Jones
Journal:  Biol Psychiatry       Date:  2016-12-01       Impact factor: 13.382

Review 3.  Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications.

Authors:  Chen-Chen Jiang; Li-Shan Lin; Sen Long; Xiao-Yan Ke; Kohji Fukunaga; Ying-Mei Lu; Feng Han
Journal:  Signal Transduct Target Ther       Date:  2022-07-11

Review 4.  Intranasal oxytocin effects on social cognition: a critique.

Authors:  Simon L Evans; Olga Dal Monte; Pamela Noble; Bruno B Averbeck
Journal:  Brain Res       Date:  2013-11-14       Impact factor: 3.252

5.  Effects of treadmill running and swimming on plasma and brain vasopressin levels in rats.

Authors:  F Ghaemmaghami; G Gauquelin; C Gharib; D Yoccoz; D Desplanches; R Favier; A M Allevard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987

6.  Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans.

Authors:  Nadine Striepens; Keith M Kendrick; Vanessa Hanking; Rainer Landgraf; Ullrich Wüllner; Wolfgang Maier; René Hurlemann
Journal:  Sci Rep       Date:  2013-12-06       Impact factor: 4.379

7.  Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice.

Authors:  Yasuhiko Yamamoto; Mingkun Liang; Seiichi Munesue; Kisaburo Deguchi; Ai Harashima; Kazumi Furuhara; Teruko Yuhi; Jing Zhong; Shirin Akther; Hisanori Goto; Yuya Eguchi; Yasuko Kitao; Osamu Hori; Yoshitake Shiraishi; Noriyuki Ozaki; Yu Shimizu; Tomoya Kamide; Akifumi Yoshikawa; Yasuhiko Hayashi; Mitsutoshi Nakada; Olga Lopatina; Maria Gerasimenko; Yulia Komleva; Natalia Malinovskaya; Alla B Salmina; Masahide Asano; Katsuhiko Nishimori; Steven E Shoelson; Hiroshi Yamamoto; Haruhiro Higashida
Journal:  Commun Biol       Date:  2019-02-25

Review 8.  From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders.

Authors:  Adele Romano; Bianca Tempesta; Maria Vittoria Micioni Di Bonaventura; Silvana Gaetani
Journal:  Front Neurosci       Date:  2016-01-12       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.